A new study suggests that people with Alzheimer’s on the drug risperidone, an antipsychotic drug often prescribed as the brand name Risperdal, may be better off continuing to take the drug if they have not experienced negative side effects.
Because of the potential side effects, risperidone is only recommended to be prescribed for three to six months. After that point, a written explanation is required to continue the drug. A study, published in the New England Journal of Medicine and funded by the National Institutes of Health, investigated the effects of discontinuing the medication among individuals who had seen improvements as a result of the drug. Researchers prescribed risperidone to individuals with Alzheimer’s disease who showed signs of agitation and aggression. After 16 weeks, researchers put half of the individuals who did well on the drug on a placebo. The other half continued the treatment. The study found that those on the placebo were twice as likely to have their symptoms return. The rate of side effects and death were equal among the two groups.
Researchers warned that antipsychotics can carry the risk of serious side effects and should not be used on all individuals with Alzheimer’s disease, but discontinuing medication that has achieved benefits is not always the right choice. "One must be cautious about discontinuing the medication,” said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City. “If a person does well on it and there are not too many side effects, maybe they should stay on it for a while and be monitored closely."
For more information, read the article: Some With Alzheimer's Better Off Staying on Antipsychotics: Study Or, read the full study: Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.
cheatsheet, Facts and Figures, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Reports
New data show that Alzheimer’s disease is going to be a greater epidemic worldwide than previously thought. A new report suggests a 17% increase in th...
Clinical Quality and Quality Care Delivery, Federal Agency Activity, Health Care
The Health and Human Services Department has awarded $55.5 million in funding to strengthen training for health professionals and to increase the size...
The Health and Human Services Department has appointed former U.S. Rep. Dennis Moore (D-KS) to the Advisory Council on Alzheimer’s Research, Care and ...
cheatsheet, Disabilities, Facts and Figures, Family Caregiver, Health and Wellness, Medication Management, Reports
Family caregivers who also have jobs face stress in managing a set of complex tasks including administering medications, caring for wounds, meeting di...
The American Geriatrics Society has released new and updated guidelines on caring for older adults with diabetes. The 2013 guidelines emphasize indivi...
The Assisted Living Federation of America has signed on to a letter sent by the Leaders Engaged on Alzheimer’s Disease (LEAD) Coalition to the U.S. Pr...
cheatsheet, Facts and Figures, Memory Care Best Practices and Research, Memory Care Education, Physical Plant, Reports
The Northeast houses more residential care communities with dementia special care apartments than other areas of the country, and that’s just one of t...
End of Life, Facts and Figures, Health and Wellness, Reports, VSED
While most Americans say there are some circumstances in which medical professionals should allow patients to die, a growing minority says doctors and...
Clinical Quality and Quality Care Delivery, Federal Agency Activity, Health Care, Medicare
Physicians and policymakers generally agreed during a healthcare seminar that permanent reform of the Medicare physician payment system and a shift to...
Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Reports, Research
People familiar with more than one language showed a later onset of dementia, according to a new study from Indian researchers.